Literature DB >> 17240067

Dimensions of "unidimensional" ratings of pain and emotions in patients with chronic musculoskeletal pain.

Alexa Huber1, Anna Lisa Suman, Carmela Anna Rendo, Giovanni Biasi, Roberto Marcolongo, Giancarlo Carli.   

Abstract

The use of unidimensional scales to measure pain intensity has been criticised because of the multidimensional nature of pain. We conducted multiple linear regression analyses to determine which dimensions of pain--sensory versus affective--predicted scores on unidimensional scales measuring pain intensity and emotions in 109 Italian women suffering from chronic, non-malignant musculoskeletal pain. We then compared the results with earlier findings in two groups of cancer patients suffering from acute post-operative pain and chronic cancer-related pain, respectively. Age, physical capacity and scores on the multidimensional affect and pain survey (MAPS) were used to predict patients' ratings on one visual analogue scale (VAS) and three numerical rating scales (NRS) measuring pain intensity, anxiety and depressed mood. Unidimensional pain intensity ratings were predicted better from sensory than from affective pain predictors, and the affective predictors made no unique contribution (NRS), or only a very small one (VAS). Both sensory and emotional pain aspects were unique predictors of NRS anxiety and depression. Therefore, in contrast to earlier findings in two different types of cancer patients, in subjects affected by chronic non-malignant musculoskeletal pain, the scores on unidimensional pain intensity scales mainly reflect sensory pain dimensions, supporting the discriminant validity of the NRS and VAS used. However, the patients had some difficulty in distinguishing between sensory and emotional information. For this reason, several unidimensional scales to rate pain intensity and emotions separately should be used to obtain a complete picture of the status and needs of any given patient.

Entities:  

Mesh:

Year:  2007        PMID: 17240067     DOI: 10.1016/j.pain.2006.11.014

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  8 in total

1.  Mood Spectrum Disorders and Perception of Pain.

Authors:  Antonella Ciaramella
Journal:  Psychiatr Q       Date:  2017-12

2.  Further evaluation of the Motivational Model of Pain Self-Management: coping with chronic pain in multiple sclerosis.

Authors:  Anna L Kratz; Ivan R Molton; Mark P Jensen; Dawn M Ehde; Warren R Nielson
Journal:  Ann Behav Med       Date:  2011-06

Review 3.  Biofield therapies: helpful or full of hype? A best evidence synthesis.

Authors:  Shamini Jain; Paul J Mills
Journal:  Int J Behav Med       Date:  2010-03

4.  Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer.

Authors:  M M Cherrier; S Aubin; C S Higano
Journal:  Psychooncology       Date:  2009-03       Impact factor: 3.894

5.  The WOMAC Pain Scale and Crosstalk From Co-occurring Pain Sites in People With Knee Pain: A Causal Modeling Study.

Authors:  Daniel L Riddle; Robert A Perera
Journal:  Phys Ther       Date:  2020-09-28

6.  The visual time analog scale: simple, novel measurement approach to assess pain in patients with chronic pain.

Authors:  Akiko Okifuji; Reiko Mitsunaga; Yuri Kida; Gary W Donaldson
Journal:  Pain Manag       Date:  2021-02-15

7.  Is there a relationship between self-efficacy, disability, pain and sociodemographic characteristics in chronic low back pain? A multicenter retrospective analysis.

Authors:  Silvano Ferrari; Carla Vanti; Marta Pellizzer; Luca Dozza; Marco Monticone; Paolo Pillastrini
Journal:  Arch Physiother       Date:  2019-10-12

8.  Pain Assessment in the Emergency Department: A Prospective Videotaped Study.

Authors:  Hao-Ping Hsu; Ming-Tai Cheng; Tsung-Chien Lu; Yun Chang Chen; Edward Che-Wei Liao; Chih-Wei Sung; Chiat Qiao Liew; Dean-An Ling; Chia-Hsin Ko; Nai-Wen Ku; Li-Chen Fu; Chien-Hua Huang; Chu-Lin Tsai
Journal:  West J Emerg Med       Date:  2022-08-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.